NEFL and Alzheimer disease: Although the study demonstrated that a greater rate of change would indicate a higher conversion from presymptomatic to symptomatic AD, the optimal disease period at which the rate of change is most accurate, a characteristic that would further the ability of NfL as a biomarker, was not determined10.